Member Log-in

I forgot my password

Not a Member? Register

Teaching Vaccine Economics Everywhere (TVEE) Course Materials

1.     Health Economics for Vaccines

The process of creating vaccines, manufacturing, distributing, and injecting them into individuals is a complex process requiring multiple decisions by multiple groups and individuals. On the supply side there are pharmaceutical companies, regulatory authorities, distributors, and thousands of health care workers who have to make strategic choices. On the demand side there are parents, relatives, friends, and their social network who have to choose to receive a vaccine and the scheduled boosters. After they receive a vaccine, they may or may not change their exposure to risks of disease.

The field of economics can be helpful at understanding decisions related to supply and demand. Economics focuses on choice under uncertainty. This course will review the relevant components of economics that can help inform decisions that drive the supply and demand for vaccines. There is a common misconception that economics is only relevant to goods that trade on the private market-and vaccines are heavily subsidized and provided publicly in most cases. However, the principles of supply and demand still apply to publicly provided goods and the economic principles are enriched by the need to understand how these private decision impact the entire public.

2.     Costing in Vaccine Planning and Programming

Costs and costing information is an important and useful input to the routine planning, budgeting, management, and implementation or rollout of an effective immunization program. This information is also needed when conducting economic evaluation studies to determine what, when and how to introduce new vaccines or which implementation approach/strategy would achieve better and effective coverage. The costs are not generalizable from one country to another as vaccine schedules, target populations, strategies etc. vary by country. For this reason, costs are country-specific and should be obtained and estimated locally.

This course provides information on the cost profiles of routine immunization programs and supplementary immunization activities (SIA) using different country examples. We will learn how to cost existing programs, specific interventions, new vaccine introduction, and possible data sources to conduct such analysis and how to report and use the results for policy decisions.

3.     Economic Evaluation of Vaccines and Vaccination Programs

Economic evaluation studies are conducted to determine what, when and how to introduce new vaccines or which implementation approach/strategy would achieve better and effective coverage. This course will enable students to have a solid introduction to the theory, methods, and application of economic evaluation in health care with a specific focus on decision analysis and cost-effectiveness analysis. alternative approaches of modeling research questions for these fields. Approaches include calculation of costs and effectiveness measures using standard modeling methods. Compares outputs as a result of decision tree and Markov modeling and introduces sensitivity analysis.

You May Also Like

Assessing the Incremental Costs and Savings of Introducing Electronic Immunization Registries and Stock Management Systems: Evidence from the Better Immunization Data Initiative in Tanzania and Zambia

Introduction: poor data quality and use have been identified as key challenges that negatively impact immunization programs in low- and middle-income countries (LMICs). In addition, many LMICs have a shortage of health personnel, and staff available have demanding workloads across several health programs. In order to address these challenges, the Better Immunization Data (BID) Initiative … Continued

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

ABSTRACT Estimating the value of global investment in immunization programs is critical to helping decision makers plan and mobilize immunization programs and allocate resources required to realize their full benefits. We estimated economic benefits using cost-of-illness and value-of-a-statistical-life approaches and combined this estimation with immunization program costs to derive the return on investment from immunization … Continued

Routine Childhood Immunization During the COVID-19 Pandemic in Africa: A Benefit–risk Analysis of Health Benefits Versus Excess Risk of SARS-CoV-2 Infection

Background National immunization programs globally are at risk of suspension due to the severe health system constraints and physical distancing measures in place to mitigate the ongoing COVID-19 pandemic. We aimed to compare the health benefits of sustaining routine childhood immunization in Africa with the risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … Continued

Choose a Language